FindTrial
Sign In

TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control

TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032478
Enrollment
Unknown
Registered
2020-04-29
Start date
2020-02-03
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:TCM intervention

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnosis of national COVID-19 diagnosis and treatment protocol, including the population of Contact,suspected,confirmed patient; 2. Have signed the informed consent and agreed to be follow-up.

Exclusion criteria

Exclusion criteria: Patients who could not accept follow-up, such as could not scan the code to submit their symptom and other information.

Design outcomes

Primary

MeasureTime frame
COVID symptom;Intervention record of TCM treatment;Intervention record of anti-virus treatment;—

Secondary

MeasureTime frame
Ending situation by follow-up ;Intervention record of anti-bacteria treatment;Change of disease condition;—

Countries

China

Contacts

Public ContactTong Xiaolin

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

xiaolintong66@sina.com+86 010-88001260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026